The press releases (PRs) on “Structural Heart Devices Market” added by Big Market Research will enable major enterprises unlocks the real-time data pertaining to the overall industry performance across different regions.
Structural heart disease refers to cardiac defects that are congenital in nature and can also be acquired through wear & tear of heart valves or chambers of the heart. Rapid advancements in the medical field have replaced the open heart surgical procedures with non-surgical minimally invasive procedures such as transcatheter aortic valve replacement (TAVR) and transcatheter mitral valve repair (TMVR).
To Order For a Sample Report Copy, Please Visit: https://goo.gl/qsU7xx
Currently, the global structural heart devices market is growing at a steady pace owing to the rise in incidence of structural heart diseases (aortic stenosis and mitral regurgitation) and development of minimally invasive technologies. According to the Micro Interventional Devices, Inc., about 60 million people in the U.S. suffer from structural heart defects. Moreover, as per the National Heart, Lung and Blood Institute, more than 35,000 babies are born with congenital heart defects in the U.S. These estimates are expected to boost the demand for structural heart devices during the forecast period. High cost of surgeries, risks associated with these surgeries, and lack of skilled cardiologists restrict this market growth. However, emerging markets (India and China) and increase in demand for structural heart procedures are expected to provide lucrative opportunities to the key players.
Enquire about the Complete Report here: https://goo.gl/bd0m0O
The report segments the market based on product type, indication, age group, and geography. Based on product type, the market is bifurcated into repair devices (annuloplasty rings, heart valve balloons, and occluders) and replacement valves (mechanical and tissue heart valves]. Based on indication, it is divided into atrial septal defect (ASD), patent foramen ovale (PFO), and ventricular septal defect (VSD), aortic valve stenosis, and others. In terms of age group, it is further categorized as pediatrics and adults. The pediatrics’ age group is segmented into newborns (0–5 months), infants (6 months to 12 months), toddlers (1–2 years), preschoolers (3–5 years), school-aged children (6–12 years), and adolescents (13–18 years). The adult age group market is further segmented into young adults (19–24 years), adulthood (25–39 years), middle-aged (40–59 years), older people/old age (60–84 years), and very old (85+ years). Geographically, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Our strength is in our research analysts who with their proactive approach are able to source best and correct information which can be detrimental in organizations success. We follow six sigma standards leaving no scope for error.
Big Market Research uniqueness lies in its highly ethical reports at economical rates because we value your relationship and growth more than money. Your growth is our aim.